Free Access
Med Sci (Paris)
Volume 21, Décembre 2005
Métabolisme glucidolipidique et risque cardiovasculaire: Nouvelle approches
Page(s) 33 - 36
Section M/S revues
Published online 15 November 2005
  1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287 : 1308–20. [Google Scholar]
  2. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management and enzyme replacement therapy. Ann Intern Med 2003; 138 : 338–46. [Google Scholar]
  3. Hagège A, Schwartz K, Desnos M, Carrier L. Genetic basis and genotype-phenotype relationships in familial hypertrophic cardiomyopathy. In: Maron BJ, ed. Diagnosis and management of hypertrophic cardiomyopathy. Cambridge USA: Blackwell Futura, 2004. [Google Scholar]
  4. Shah JS, Elliott PM. Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapy. Acta Paediatr 2005; 94 (suppl): 11–4. [Google Scholar]
  5. Kampmann C, Baehner F, Whybra C, et al. Cardiac manifestations of Anderson-Fabry disease in heterozygous females. J Am Coll Cardiol 2002; 40 : 1668–74. [Google Scholar]
  6. Linhart A, Lubanda JC, Palecek T, et al. Cardiac manifestations in Fabry disease. J Inherit Metab Dis 2001; 24 (suppl 2): 75–83. [Google Scholar]
  7. Nakao S, Takenaka T, Maeda M, et al. An Atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med 1995; 333 : 288–93. [Google Scholar]
  8. Sachdev B, Takenaka T, Teraguchi H, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002; 105 : 1407–11. [Google Scholar]
  9. Chimenti C, Pieroni M, Morgante E, et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 2004; 110 : 1047–53. [Google Scholar]
  10. Ommen SR, Nishimura RA, Edwards WD. Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy ? Heart 2003; 89 : 929–30. [Google Scholar]
  11. Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005; 352 : 362–72. [Google Scholar]
  12. Pieroni M, Chimenti C, Ricci R, et al. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 2003; 107 : 1978–84 [Google Scholar]
  13. Nagueh SF, McFalls J, Meyer D, et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 2003; 108 : 395–8. [Google Scholar]
  14. Spinelli L, Pisani A, Sabbatini M, et al. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry’s disease. Clin Genet 2004; 66 : 158–65. [Google Scholar]
  15. Weidemann F, Breunig F, Beer M, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 2003; 108 : 1299–301. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.